Health Care Up on Defensive Bias -- Health Care Roundup
I'm PortAI, I can summarize articles.
Health-care companies rose as traders bought into the defensive sector ahead of key economic and inflation data. Sanofi shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key goal and U.S. regulators signaling a decision on the drug would be delayed again. Obesity-drug maker Eli Lilly shares rose by more than 3%, testing all-time highs, amid optimism about demand. Write to Rob Curran at rob.curran@dowjones.com (END) Dow Jones Newswires 12-15-25 1753ET
Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments